Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Proto-oncogene c-Fos is a nuclear protein that functions as a critical component of the dimeric Activator Protein-1 (AP-1) transcription factor complex (Wikipedia, UniProt). It is classified as an "immediate early gene" because its expression is rapidly and transiently induced within minutes of exposure to extracellular stimuli such as growth factors, cytokines, and neurotransmitters (PubMed, Wikipedia). By heterodimerizing with Jun family proteins via a basic leucine zipper domain, c-Fos binds to specific DNA sequences to regulate genes involved in cell proliferation, differentiation, and survival (UniProt, NCBI). Dysregulation of c-Fos is a hallmark of various pathological conditions; its overexpression is strongly associated with the progression of numerous cancers, including breast, lung, and bone tumors (PubMed, NCBI). In the central nervous system, c-Fos expression serves as a widely used biomarker for neuronal activation and is implicated in the pathophysiology of epilepsy and chronic pain (PubMed). While traditionally difficult to target directly, research efforts focus on small-molecule inhibitors such as T-5224, which aim to disrupt the c-Fos/AP-1 DNA-binding interface to treat inflammatory and malignant diseases (PubMed).
Inhibition of the AP-1 transcription factor complex by preventing c-Fos from binding to DNA or dimerizing with Jun family proteins, as well as the modulation of upstream signaling pathways like the MAPK/ERK cascade that regulate its expression.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proto-oncogene c-Fos (c-Fos) (c-Fos).